Welcome Logout
Skip to main content
H-S-E homepage

National Cancer Control Programme

  • Home
  • About Us
    • NCCP Children Adolescent & Young Adult Cancer Programme
    • Regional Cancer Services
    • NCCP Structure and Governance
  • Cancer Prevention
  • Patients and Families
    • Cancer Screening
    • Cancer Treatments
      • Surgery
      • Radiotherapy
      • Cancer Drugs
    • Information Leaflets and Booklets
  • Publications, Research and Intelligence
    • Reports
    • Cancer Intelligence
    • NCCP Guidelines and Policies
    • NCCP Research
  • NCCP Consultations
  • Health Professionals
    • Cancer Nursing Programme
    • Cancer Screening
    • Clinical Practice Guidelines
      • Breast Cancer National Clinical Guidelines
      • Prostate Cancer National Clinical Guidelines
      • Lung Cancer National Clinical Guidelines
      • Gestational Trophoblastic Disease
      • Ovarian Cancer National Clinical Guidelines
      • Oesophageal Cancer National Clinical Guidelines
      • Rectal Cancer National Clinical Guidelines
    • Community Pharmacy
    • Education and Training Resources
    • Hereditary Cancer Genetics
    • Medical Oncology and Haemato-oncology
      • Cancer Drug Management Programme
      • Chimeric Antigen Receptor T-Cell (CAR-T)
      • Clinical Trials for Cancer Patients
      • Contact the National Medical Oncology and Haemato-oncology Programme
      • Dose Banding for Systemic Anticancer Therapy
      • Haemato-oncology Patient Pathways
      • Molecular Diagnostics Advisory Group
      • National Meeting
      • NCCP Technology Review Committee
      • NCIS
      • Oncology Medication Safety Review
      • Peptide Receptor Radionuclide Therapy (PRRT)
      • SACT Guidance, Documents and Resources
    • NCCP National SACT Regimens
      • Breast
      • CAR-T Therapy
      • Gastrointestinal
      • Genitourinary
      • Gynaecology
      • Head & Neck
      • Leukaemia and Myeloid Neoplasms
      • Lung
      • Lymphoma and Other Lymphoproliferative Disorders
      • Neuroendocrine
      • Neuro-oncology
      • Oral Anti-Cancer Medicines
      • Paediatric
      • Plasma Cell Disorders
      • Sarcoma
      • Skin / Melanoma
      • Supportive Care
      • Transplant
      • Tumour Agnostic Therapy
    • Primary Care Resources
      • GP Referral Guidelines and Forms
      • GP Electronic Referral System
    • Psycho-Oncology Programme
    • Publications, Research and Intelligence
    • Radiation Oncology
    • Survivorship Programme
    • Tumour Conference SOPs
  • News and Events: Cancer Services
  • About Us
  • Cancer Prevention
  • Patients and Families
  • NCCP Consultations
  • Health Professionals
  • News and Events: Cancer Services
  1. National Cancer Control Programme
  2. Publications, Research and Intelligence
  3. Reports

Cancer reports

Published reports from NCCP, HSE, Department of Health and other cancer-related reports are listed below.

Cancer Prevention

  • National Skin Cancer Prevention Plan 2023-2026
  • National Skin Cancer Prevention Plan 2019-2022; Implementation Review 2020
  • National Skin Cancer Prevention Plan 2019-2022 
  • Skin Cancer Prevention Survey 2019 Summary of Key Findings
  • National Cancer Control Programme: Skin Cancer Prevention Survey 2019

Early Detection

  • NCCP Early Diagnosis of Symptomatic Cancer Plan 2022-2025
  • Lung Cancer Detection: a Qualitative Study Among High-Risk Individuals.pdf October 2020, NCCP & UCC
  • National Survey on Lung Cancer Awareness Report January 2020

CAYA

  • Framework for the Care and Support of Adolescent and Young Adults (AYA) with cancer in Ireland
  • Child, Adolescent and Young Adult (CAYA) Cancer Annual Report for 2021

Cancer Survivorship

  • Needs Assessment: Living with and Beyond Cancer in Ireland
  • Needs Assessment: Acute Sector Cancer Survivorship Services in the Irish Context
  • Needs Assessment: Survivorship after Childhood Cancer, 2018
  • Needs Assessment: The Unmet Needs of Cancer Survivors in Ireland: A Scoping Review 2019

Systemic Anti-Cancer Therapy

  • SACT Guidance, Documents and Resources
  • Oncology Medication Safety Review Report
  • Oral anti-cancer medicines 2018

Public Health

  • NCCP Response to the initial wave of the Covid-19 pandemic

Page last updated 23/04/2024

 
  • About Us
  • Cancer Prevention
  • Patients and Families
  • Publications, Research and Intelligence
    • Reports
    • Cancer Intelligence
    • NCCP Guidelines and Policies
    • NCCP Research
  • NCCP Consultations
  • Health Professionals
  • News and Events: Cancer Services
  • Services
    • All Health Services
    • Latest News
    • My health my language
    • COVID-19 resources and translations
    • Publications and Reports
    • Urgent and emergency care (TrolleyGAR)
    • You and Your Health Service
    • Order HSE resources
    • Healthcare in Ireland
  • Health A to Z
    • Baby and Child Health
    • Immunisation
    • Healthy Ireland
  • Staff and Careers
    • Jobs
    • Online payslips
    • Training
    • Staff resources
    • Staff engagement
    • PCRS Online
    • Health Service Excellence Awards 2024
  • About Us
    • Our Health Service
    • HSE Structure
    • National Quality and Patient Safety Directorate
    • Public Representatives
    • Non Statutory Sector
    • FOI Publication Scheme

Contact Us

For questions about health services, your entitlements, or how to access HSE health or social services in your area?

You can phone HSELive to speak to one of our agents on: 

1800 700 700

00 353 1 240 8787 (from outside Ireland)

Get more information about this service including opening hours

Privacy statement   Disclaimer   Cookie statement   Accessibility   © 2024 Health Service Executive

  • Cookie Settings
  • Cookie Statement
  • Accessibility
  • Privacy Statement
  • Disclaimer